Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  El Ridi, Rashika ^a   Tallima, Hatem ^a   Selim, Sahar ^b   Donnelly, Sheila ^c   Cotton, Sophie ^d   Santana, Bibiana Gonzales ^d   Dalton, John P ^d,e  

^a CAIRO UNIVERSITY   (Egypt)

^b MENOUFIA UNIVERSITY   (Egypt)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^d MCGILL UNIVERSITY   (Canada)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN L; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PEROXIREDOXIN; SCHISTOSOMA VACCINE;

ADULT; ANIMAL CELL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FASCIOLA HEPATICA; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; MALE; MOUSE; NONHUMAN; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TH2 CELL; WORM EGG;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CATHEPSIN B; CATHEPSINS; FASCIOLA HEPATICA; FEMALE; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (NADP+); IMMUNITY, ACTIVE; MICE; PEROXIREDOXINS; PICHIA; RECOMBINANT PROTEINS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINATION; VACCINES, SUBUNIT;

EID: 84905672787     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085401     Document Type: Article

References (58)

1. King CH (2010) Parasites and poverty: the case of schistosomiasis. Acta Trop 113: 95-104.
2. Gray DJ, McManus DP, Li Y, Williams GM, Bergquist R, et al. (2010) Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect Dis 10: 733-736.
3. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197-2223.
4. Stirewalt MA (1974) Schistosoma mansoni: cercaria to schistosomule. Adv Parasitol 12:115-182.
5. Walker AJ (2011) Insights into the functional biology of schistosomes. Parasit Vectors 4: 203.
6. Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, et al. (2009) The genome of the blood fluke Schistosoma mansoni. Nature 460: 352-358.
7. Bos DH, Mayfield C, Minchella DJ (2009) Analysis of regulatory protease sequences identified through bioinformatic data mining of the Schistosoma mansoni genome. BMC Genomics 10: 488.
8. Driguez P, Doolan DL, Loukas A, Felgner PL, McManus DP (2010) Schistosomiasis vaccine discovery using immunomics. Parasit Vectors 3: 4.
9. Da'dara AA, Skelly PJ, Fatakdawala M, Visovatti S, Eriksson E, et al. (2002) Comparative efficacy of the Schistosoma mansoni nucleic acid vaccine, Sm23, following microseeding or gene gun delivery. Parasite Immunol 24: 179-187. (Pubitemid 34534239)
10. Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, et al. (2006) Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 12: 835-840. (Pubitemid 44050075)
11. Farias LP, Cardoso FC, Miyasato PA, Montoya BO, Tararam CA, et al. (2010) Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection. PLoS Negl Trop Dis 4: e597.
12. McManus DP, Loukas A (2008) Current status of vaccines for schistosomiasis. Clin Microbiol Rev 21: 225-242. (Pubitemid 351160017)
13. Siddiqui AA, Siddiqui BA, Ganley-Leal L (2011) Schistosomiasis vaccines. Hum Vaccin 7: 1192-1197.
14. El Ridi R, Tallima H, Mahana N, Dalton JP (2010) Innate immunogenicity and the in vitro protective potential of Schistosoma mansoni lung schistosomula excretory-secretory candidate vaccine antigens. Microbes Infect 12: 700-709.
15. Maizels RM, Hewitson JP, Smith KA (2012) Susceptibility and immunity to helminth parasites. Curr Opin Immunol 24: 459-466.
16. El Ridi R, Tallima H (2013) Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines. J Parasitol 99: 194-202.
17. Chapman MD, Wünschmann S, Pomés A (2007) Proteases as Th2 adjuvants. Curr Allergy Asthma Rep 7: 363-367. (Pubitemid 47377325)
18. Tang H, Cao W, Kasturi SP, Ravindran R, Nakaya HI, et al. (2010) The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. Nat Immunol 11: 608-617.
19. Liang G, Barker T, Xie Z, Charles N, Rivera J, et al. (2012) Naive T cells sense the cysteine protease allergen papain through protease-activated receptor 2 and propel TH2 immunity. J Allergy Clin Immunol 129: 1377-1386.
20. Cunningham PT, Elliot CE, Lenzo JC, Jarnicki AG, Larcombe AN, et al. (2012) Sensitizing and Th2 adjuvant activity of cysteine protease allergens. Int Arch Allergy Immunol 158: 347-358.
21. Zerda KS, Dresden MH, Chappell CL (1988) Schistosoma mansoni: expression and role of cysteine proteinases in developing schistosomula. Exp Parasitol 67: 238-246. (Pubitemid 19008832)
22. Caffrey CR, Rheinberg CE, Moné H, Jourdane J, Li YL, et al. (1997) Schistosoma japonicum, S. mansoni, S. haematobium, S. intercalatum, and S. rodhaini: cysteine-class cathepsin activities in the vomitus of adult worms. Parasitol Res 83: 37-41.
23. Brady CP, Dowd AJ, Brindley PJ, Ryan T, Day SR, et al. (1999) Recombinant expression and localization of Schistosoma mansoni cathepsin L1 support its role in the degradation of host hemoglobin. Infect Immun 67: 368-374. (Pubitemid 29021671)
24. Brady CP, Dowd AJ, Tort J, Roche L, Condon B, et al. (1999) The cathepsin L-like proteinases of liver fluke and blood fluke parasites of the trematode genera Fasciola and Schistosoma. Biochem Soc Trans 27: 740-745. (Pubitemid 29412522)
25. Skelly PJ, Shoemaker CB (2001) Schistosoma mansoni proteases Sm31 (cathepsin B) and Sm32 (legumain) are expressed in the cecum and protonephridia of cercariae. J Parasitol 87: 1218-1221. (Pubitemid 32995694)
26. Caffrey CR, Salter JP, Lucas KD, Khiem D, Hsieh I, et al. (2002) SmCB2, a novel tegumental cathepsin B from adult Schistosoma mansoni. Mol Biochem Parasitol 121: 49-61. (Pubitemid 34457833)
27. Dvorák J, Mashiyama ST, Sajid M, Braschi S, Delcroix M, et al. (2009) SmCL3, a gastrodermal cysteine protease of the human blood fluke Schistosoma mansoni. PLoS Negl Trop Dis 3: e449.
28. Stack CM, Dalton JP, Cunneen M, Donnelly S (2005) De-glycosylation of Pichia pastoris - produced Schistosoma mansoni cathepsin B eliminates non-specific reactivity with IgG in normal human serum. J Immunol Meth 304: 151-157. (Pubitemid 41262229)
29. Brady CP, Brindley PJ, Dowd A J, Dalton JP (2000) Schistosoma mansoni: differential expression of cathepsins L1 and L2 suggests discrete biological functions for each enzyme. Exp Parasitol 94: 75-83. (Pubitemid 30124105)
30. Collins PR, Stack CN, O'Neill SM, Doyle S, Ryan T, et al. (2004) Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: propeptide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells. J Biol Chem 279: 17038-17046. (Pubitemid 38560458)
31. Stack CM, Caffrey CR, Donnelly SM, Seshaadri A, Lowther J, et al. (2008) Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica. J Biol Chem 283: 9896-9908.
32. Dvorák J, Mashiyama ST, Braschi S, Sajid M, Knudsen GM, (2008) Differential use of protease families for invasion by schistosome cercariae. Biochimie 90: 345-358. (Pubitemid 351172572)
33. El Ridi R, Shoemaker CB, Farouk F, El Sherif NH, Afifi A et al. (2001) Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapy. Infect Immun 69: 237-244. (Pubitemid 32040948)
34. Donnelly S, Stack CM, O'Neill SM, Sayed AA, Williams DL, et al. (2008) Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J 22: 4022-4032.
35. Gaafar T, Ismail S, Helmy M, Afifi A, Guirguis N, et al. (1993) Identification of Schistosoma haematobium soluble egg antigens that elicit human granuloma formation in vitro. Parasitol Res 79: 103-108. (Pubitemid 23072158)
36. El Ridi R, Mohamed SH, Tallima H (2003) Incubation of Schistosoma mansoni lung-stage schistosomula in corn oil exposes their surface membrane antigenic specificities. J Parasitol 89: 1064-1967.
37. Tallima H, Montash M, Veprek P, Velek J, Jezek J, et al. (2003) Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase. Vaccine 21: 3290-4300.
38. Chapoval SP, Nabozny GH, Marietta EV, Raymond EL, Krco CJ, et al. (1999) Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice. J Clin Invest 103: 1707-1717. (Pubitemid 29534365)
39. Sokol CL, Barton GM, Farr AG, Medzhitov R (2008) A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 9: 310-318. (Pubitemid 351267328)
40. Sokol CL, Chu NQ, Yu S, Nish SA, Laufer TM, et al. (2009) Basophils function as antigen presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 10:713-720.
41. Sokol CL, Medzhitov R (2010) Role of basophils in the initiation of Th2 responses. Curr Opin Immunol 22: 73-77.
42. Dean DA, Mangold BL (1984) Autoradiographic analysis of resistance to reinfection with Schistosoma mansoni in mice. Evidence that the liver is a major site of worm elimination. Am J Trop Med Hyg 33: 97-103. (Pubitemid 14190448)
43. Davies SJ, Grogan JL, Blank RB, Lim KC, Locksley RM, et al. (2001) Modulation of blood fluke development in the liver by hepatic CD4+ lymphocytes. Science 294: 1358-1361. (Pubitemid 33063105)
44. Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A (1991) Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med 173: 159-166.
45. de Oliveira Fraga LA, Torrero MN, Tocheva AS, Mitre E, Davies SJ (2010) Induction of type 2 responses by schistosome worms during prepatent infection. J Infect Dis 201: 464-472.
46. de Oliveira Fraga LA, Lamb EW, Moreno EC, Chatterjee M, Dvoøák J, et al. (2010) Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection. BMC Immunol 11: 56.
47. Dean DA (1983) Schistosoma and related genera: acquired resistance in mice. Exp Parasitol 55: 1-104.
48. Wynn TA (1999) Immune deviation as a strategy for schistosomiasis vaccines designed to prevent infection and egg-induced immunopathology. Microbes Infect 1: 525-534.
49. Xu X, Zhang D, Sun W, Zhang Q, Zhang J, et al. (2009) Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens. BMC Infect Dis 9: 54.
50. El Ridi R, Ozaki T, Sato H, Inaba T, Kamiya H (1997) Immunization of mice with ultraviolet-attenuated cercariae of Schistosoma mansoni transiently reduces the fecundity of challenge worms. Int J Parasitol 27: 581-586. (Pubitemid 27278188)
51. Dalton JP, Clough KA, Jones MK, Brindley PJ (1996) Characterization of the cathepsin-like cysteine proteinases of Schistosoma mansoni. Infect Immun 64: 1328-1334. (Pubitemid 26102397)
52. Abdulla MH, Lim KC, Sajid M, McKerrow JH, Caffrey CR (2007) Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med 4: e14.
53. Chappell CL, Kalter DC, Dresden MH (1988) The hypersensitivity response to the adult worm proteinase, SMw32, in Schistosoma mansoni infected mice. Am J Trop Med Hyg 39: 463-468.
54. Chappell CL, Dresden MH, Gryseels B, Deelder AM (1990) Antibody response to Schistosoma mansoni adult worm cysteine proteinases in infected individuals. Am J Trop Med Hyg 42: 335-341. (Pubitemid 20137305)
55. Ganley-Leal LM, Mwinzi PN, Cetre-Sossah CB, Andove J, Hightower AW, et al. (2006) Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans. Infect Immun 74: 2169-2176.
56. Jiz M, Friedman JF, Leenstra T, Jarilla B, Pablo A, et al. (2009) Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4. Infect Immun 77: 2051-2058.
57. Figueiredo JP, Oliveira RR, Cardoso LS, Barnes KC, Grant AV, et al. (2012) Adult worm-specific IgE/IgG4 balance is associated with low infection levels of Schistosoma mansoni in an endemic area. Parasite Immunol 34: 604-610.
58. Fitzsimmons CM, Jones FM, Pinot de Moira A, Protasio AV, Khalife J, et al. (2012) Progressive cross-reactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis? Infect Immun 80: 4264-4270.